题名 | Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trials. |
作者 | Driscoll JJ, Rixe O. |
杂志 | Cancer J. 2009 Sep-Oct;15(5):401-5. |
链接 | http://www.ncbi.nlm.nih.gov/pubmed/19826360 |
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |